Nelson Hardiman managing partner Harry Nelson presented at the 13th Annual Family Office Investment Symposium where he discussed the four main buckets of potential life sciences investing, including 1) pharma/biotech, 2) medical devices, 3) neutraceuticals, supplements, and cosmeceuticals, and 4) clinical research and technology transfer.
Posted on February 27, 2018
Recent Posts
The Inevitable Implosion of Healthcare PrivacyHarry Nelson Interviewed on BBC News: US to require negative Covid tests for travelers from ChinaHarry Nelson Interviewed on NewsNation Banfield: Fears over old sports medical forms and girls menstrual informationA View from Legal Street, Help Us Help You Get Paid, Episode 14: The Revenue Solution – TJ FerrisHarry Nelson Interviewed on KTLA 5 regarding the rise in fentanyl deaths amid $650M pharmacy judgment